Brief: Immunovant Provides Corporate Updates And Reports Q4 And Fiscal Year Ended March 31, 2023 Financial Results

Immunovant

22/05/2023 12:46

May 22 (Reuters) - Immunovant Inc  IMVT.O :
    * IMMUNOVANT PROVIDES CORPORATE UPDATES AND REPORTS
FINANCIAL
RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED MARCH 31,
2023
    * IMMUNOVANT - AS OF MARCH 31, 2023, CASH AND CASH
EQUIVALENTS
TOTALED $376.5 MILLION, EXPECTED TO FUND OPERATIONS INTO H2 OF
CALENDAR YEAR 2025
    * QTRLY LOSS PER SHARE $0.46
    * Q4 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX73qwsW 
Further company coverage:  IMVT.O 

 ((Reuters.Briefs@thomsonreuters.com;))